Monday, September 14, 2026

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

NewJeans’ Parents Speak Out on Instagram Amid Agency Dispute, Share Struggles with Media

The parents of NewJeans take to Instagram to share their side of the dispute with HYBE, addressing misrepresentation concerns.

How Angeliq and Other Treatments Are Transforming Menopausal Care in 2026

Daewon Pharmaceutical's symposium focused on menopausal hormone therapy, featuring discussions on Angeliq and recent clinical findings.

Tag: SIA

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.